About: Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.11 (+0.16%)
ARDX NASDAQ Ardelyx Inc
Ardelyx Inc share price
Atividade de preço de ARDX
Último preço
$ 3,110
Variação (24h)
0,01 USD (0,16%)
Volume
1.81M
Volume (média 4 sem.)
-
Abertura
$ 3,12
Variação do dia
$ 3,08 - $ 3,16
Fechamento anterior
$ 3,10
Último negócio
29 Oct, 7:50 pm GMT+0
Atrasado
29 Oct, 7:50 pm GMT+0
ARDX price performance
Atrasado
29 Oct, 7:50 pm GMT+0
quote.marketSignals